The high tumorigenicity of C1s has been noted in both renal cell carcinoma and cutaneous squamous cell carcinoma, highlighting its promise as a target for cancer therapy (Riihilä et al., 2020; Liu et al., 2021). The gene discussed is C1S; the disease is cutaneous squamous cell carcinoma.